Fizazi, A.; Serrand, C.; Evrard, A.; Bergeret, B.; Stoebner, P.-E.; Marque, M. High BRAF V600 Mutation Level Associated With Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors. Acta Derm Venereol 2024, 104, adv40913.